Skip to content

Clinical trials

Attention Deficit Disorder with Hyperactivity trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Country / region: China Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20111
20121
20132
20141
20162
20171
20183
20192
20202
20214
20224
20238
202410
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status14
Recruiting12
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chen Li5
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine5
Children's Hospital of Fudan University4
Eli Lilly and Company3
Peking University3
First Affiliated Hospital Xi'an Jiaotong University2
First Affiliated Hospital of Zhejiang University2
Qilu Hospital of Shandong University2
Xijing Hospital2
Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity53
Autism Spectrum Disorder2
Intellectual Disability2
Autistic Disorder1
Brain Neoplasms1
Cerebral Palsy1
Cerebrovascular Disorders1
Depressive Disorder1
Developmental Disabilities1
Epilepsy1

Trials

Showing 76 to 53 of 53. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.